Trevi Therapeutics GAAP EPS of -$0.14 beats by $0.04

Aug. 11, 2022 4:30 PM ETTrevi Therapeutics, Inc. (TRVI)By: Manshi Mamtora, CFA
  • Trevi Therapeutics press release (NASDAQ:TRVI): Q2 GAAP EPS of -$0.14 beats by $0.04.
  •  Company had total cash, cash equivalents and marketable securities of $78.9 million.

Recommended For You


To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.